HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NNC 55-0118

Also Known As:

NNC-55-0118

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazides: 1584
    - Benzothiadiazines: 3
      - Diazoxide: 1200
        NNC 55-0118: 2
  - Sulfones: 534
    - Sulfonamides: 2809
      - Benzothiadiazines: 3
        Diazoxide: 1200
        NNC 55-0118: 2
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzothiadiazines: 3
      - Diazoxide: 1200
        NNC 55-0118: 2

Experts

1.	Bodin, Birgitta: 1 article (08/2003)
2.	Hansen, John Bondo: 1 article (08/2003)
3.	Jansson, Leif: 1 article (08/2003)
4.	Karlsson, F Anders: 1 article (08/2003)
5.	Kullin, Mikael: 1 article (08/2003)
6.	Sandler, Stellan: 1 article (08/2003)
7.	Hansen, J B: 1 article (07/2000)
8.	Hornum, L: 1 article (07/2000)
9.	Mandrup-Poulsen, T: 1 article (07/2000)
10.	Markholst, H: 1 article (07/2000)

Related Diseases

1.	Inflammation (Inflammations) 07/01/2000 - "Furthermore, rats with C-peptide response and treated with NNC 55-0118 exhibited only minimal signs of islet inflammation, whereas C-peptide responding diazoxide-treated rats had low level islet inflammation. "
2.	Hyperglycemia 08/01/2003 - "Both diazoxide and NNC 55-0118 dose-dependently increased total pancreatic and islet blood flow in the presence of moderate hyperglycemia, but had no effects on the blood perfusion of other splanchnic organs. "

Related Drugs and Biologics

1.	Diazoxide (Hyperstat)
2.	C-Peptide